Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of bacillus calmette‐guerin

4Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Eight of 64 patients receiving intravenous administration of methanol extraction residue (MER) of Bacillus Calmette‐Guerin (BCG), developed miliary‐type pulmonary parenchymal changes. The clinical and radiological characteristics are described. An increased incidence was noted in patients with a history of previous BCG exposure or with positive PPD skin reactivity. Spontaneous resolution was observed upon discontinuation of MER. These changes most likely represent a granulomatous inflammatory process, although no histological confirmation was obtained. Copyright © 1980 American Cancer Society

Cite

CITATION STYLE

APA

Quesada, J. R., Libshitz, H. I., Hersh, E. M., & Gutterman, J. U. (1980). Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of bacillus calmette‐guerin. Cancer, 45(6), 1340–1343. https://doi.org/10.1002/1097-0142(19800315)45:6<1340::AID-CNCR2820450612>3.0.CO;2-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free